Skip to content
Menu

Spyre Therapeutics, Inc. SYRE

Full chart Compare
Set alert

Price alert · SYRE

All alert types
97.63 USD -3.83 (-3.77%)

Regular-session close

97.63 0.00 0.00%

After hours · Nov 19, 4:56 PM ET

97.49 Day range 103.50
23.01 52-week range 110.64
YTD
+198.02%
1 year
+301.77%

Revenue & Expenses

Revenue Profit Costs
Income Tax Benefit$26.00KGross Profit$886.00KNet Loss$338.79MExpenses$339.70MSelling, General & Admin$39.95MResearch & Development$89.50MOther Operating Expenses$113.74MOther Expenses$96.51MRevenue$886.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

SYRE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-209.56M-208.57M-242.30M-84.78M-65.65M
-155.20M-208.02M-338.79M-83.81M-65.80M
-1.98-3.18-13.76-24.86-25.02
SYRE annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
85.72M89.42M189.22M36.42M16.98M
777.78M608.48M341.86M71.14M109.93M
62.55M90.68M73.29M20.84M25.98M
715.24M517.80M184.02M50.30M83.94M
SYRE annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-169.25M-157.41M-99.91M-80.14M-53.72M
-143.47M-353.29M-108.39M57.01M-22.62M
309.02M410.91M361.08M42.68M1.39M
-3.70M-99.79M152.80M19.44M-74.96M